Increxxa (Tulathromycin) Injectable Solution

Elanco SKU: 90208732

$245.99

Shipping calculated at checkout

Available Now!

100ml vial
250ml vial
500ml vial

Add to Cart

Rx Map

Increxxa (Tulathromycin) Injectable Solution

Increxxa contains tulathromycin, the same macrolide antibiotic veterinarians and the cattle industry have depended on to control and treat bovine respiratory disease (BRD) in cattle for more than 15 years. It’s a go-to antibiotic for beef and dairy producers because of its one-time use, extended duration of action, ease of administration and broad-spectrum control.

Indications

Beef and Non-Lactating Dairy Cattle: Treatment of bovine respiratory disease (BRD) and control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis. Treatment of infectious bovine keratoconjunctivitis (IBK) associated with M. bovis. Treatment of bovine foot rot (interdigital necrobacillosis) associated with F. necrophorum and P. levii.

Suckling Calves, Dairy Calves and Veal Calves: Treatment of BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis.

Key Benefits

  • Delivers a broad BRD solution for customers.
  • Healthier cattle and an improved bottom line.
  • Supported by Elanco's antibiotic stewardship initiatives.

Recommended Dosage

 Use as directed by your veterinarian.

In cattle, inject subcutaneously as a single dose in the neck at a dosage of 2.5 mg/kg (1.1 mL/100 lb) body weight. Do not inject more than 10 mL per injection site.

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Extra-label use of this drug in food-producing animals is prohibited. Cattle intended for human consumption must not be slaughtered within 18 days from the last treatment. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows.

Storage Instructions

Store below 25°C (77°F), with excursions up to 40°C (104°F).

100 mL: Use within 2 months of first puncture and puncture a maximum of 67 times. If more than 67 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-off spike or needle with bore diameter larger than 16 gauge, discard any product remaining in the vial immediately after use.

250 mL: Use within 2 months of first puncture and puncture a maximum of 100 times. If more than 100 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-off spike or needle with bore diameter larger than 16 gauge, discard any product remaining in the vial immediately after use.

Prescription items are NON-RETURNABLE and NON-REFUNDABLE.